Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 16, 2025 11:16 ET | Source: Research and Markets

Opportunities in the Central Nervous System (CNS) Therapeutics Market: Revenues Forecast to Reach US$156.5 Billion by 2030

Dublin, June 16, 2025 (GLOBE NEWSWIRE) -- The "Central Nervous System Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for...
May 28, 2025 09:36 ET | Source: Research and Markets

Targeted Drug Delivery Research Business Analysis Report 2024-2030 with Focus on 30+ Key Players Such as AbbVie, Amgen, AstraZeneca, Becton Dickinson and Co, & Bristol-Myers Squibb

Dublin, May 28, 2025 (GLOBE NEWSWIRE) -- The "Targeted Drug Delivery - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Targeted...
March 04, 2025 15:13 ET | Source: NanoNewron

NanoNewron Appoints Industry Veteran Marco Taglietti, M.D., as Chief Executive Officer to Lead the Company and the Development of Their Promising Alzheimer’s Compound

Marco Taglietti, MD is appointed CEO of NanoNewron, a company developing TNF-α inhibitors for Alzheimer’s, engineered to cross the Blood-Brain Barrier
February 06, 2025 12:38 ET | Source: Research and Markets

Drug Delivery Across Blood Brain Barrier (BBB) Market Eyes $2.66 Billion Revenue Opportunity by 2030, Driven by Advancements in Drug Formulations and Biologics

Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Drug Delivery Across Blood Brain Barrier Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
January 08, 2025 10:20 ET | Source: Research and Markets

Central Nervous System (CNS) Therapeutics Market Forecast (2025-2035) by Disease, Drug Class, Distribution Channel and Region

Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Central Nervous System Therapeutics Market by Disease, by Drug Class, by Distribution Channel, and by Region" report has been added to ...
December 13, 2024 09:11 ET | Source: Research and Markets

Blood Brain Barrier Technologies Market Outlook to 2028 & 2033

Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Blood Brain Barrier Technologies Market 2024" report has been added to ResearchAndMarkets.com's offering.The blood brain barrier technologies market...
October 08, 2024 12:00 ET | Source: Qinotto Inc

Qinotto and Lilly Enter Research Collaboration and License Agreement

SAN CARLOS, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Qinotto, Inc., a central nervous system (CNS) focused biopharmaceutical company that is discovering novel vehicles to deliver large molecule...
September 11, 2024 12:39 ET | Source: Research and Markets

Krabbe Disease Treatment Markets, Companies, and Growth Opportunities 2024-2030 - Advancements in Gene Therapy Expand Addressable Market

Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "Krabbe Disease Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Krabbe...
September 11, 2024 04:09 ET | Source: Research and Markets

Blood Brain Barrier Market Assessment 2024-2035, Distribution by Type of Molecule, Route of Administration, Target Disease Indication, Therapeutic Area and Key Geographical Regions

Dublin, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The "Blood Brain Barrier Market, 3rd Edition - Industry Trends and Global Forecasts to 2035: Distribution by Type of Molecule, Route of Administration,...
August 05, 2024 11:00 ET | Source: NeOnc Technologies Holdings, Inc.

NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted with Meningioma, Marking Second Concurrent Phase 2 Study of Leading CNS Cancer Drug Candidate

NeOnc’s second concurrent Phase 2 clinical study seeks further safety and preliminary evidence of biological effects of its lead drug candidate, NEO100™, on certain cancers of the brain and central...

Next Page keyboard_arrow_right